Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants

Abstract Background Uncomplicated urinary tract infections (uUTIs) are among the most common community-acquired infections for women worldwide. Treatment options are increasingly limited by antibiotic resistance; novel oral antibiotics are urgently needed. Gepotidacin is a novel, bactericidal, first...

Full description

Bibliographic Details
Published in:	Infectious Diseases and Therapy
Main Authors:	Caroline Perry, Mohammad Hossain, Marcy Powell, Aparna Raychaudhuri, Nicole Scangarella-Oman, Courtney Tiffany, Sherry Xu, Etienne Dumont, Salim Janmohamed
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2022-10-01
Subjects:	Acute cystitis Antibiotic Antimicrobial Gepotidacin Nitrofurantoin Phase III clinical trial
Online Access:	https://doi.org/10.1007/s40121-022-00706-9

Similar Items

Efficacy and Safety of Gepotidacin as Treatment of Uncomplicated Urogenital Gonorrhea (EAGLE-1): Design of a Randomized, Comparator-Controlled, Phase 3 Study
by: Caroline R. Perry, et al.
Published: (2023-09-01)

In vitro activity of the first-in-class triazaacenaphthylene gepotidacin alone and in combination with doxycycline against drug-resistant and -susceptible Mycoplasma genitalium
by: Jørgen Skov Jensen, et al.
Published: (2020-01-01)

Antibacterial Activity of the Novel Drug Gepotidacin against <i>Stenotrophomonas maltophilia</i>—An In Vitro and In Vivo Study
by: Maike Isabell Sanders, et al.
Published: (2022-02-01)

Efficacy of Five Days Nitrofurantoin Therapy versus Fosfomycin Stat Dose in Clinical Resolution of Uncomplicated Urinary Tract Infections
by: Hasham Bin Tahir, et al.
Published: (2023-02-01)

Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women
by: Asher Shafrir, et al.
Published: (2023-03-01)

Nitrofurantoin inhibits contractions of myometrium isolated from pregnant and nonpregnant rats
by: Ebru Celik Kavak, et al.
Published: (2018-06-01)

The Effect of Nitrofurantoin on Tonic Seizures Induced by MES in Male Mice
by: Azin Jalalian, et al.
Published: (2024-06-01)

Progress in Electrode Materials for the Detection of Nitrofurazone and Nitrofurantoin
by: Mohammad Aslam, et al.
Published: (2025-07-01)

The effects of nitrofurantoin on rat urinary bladder contraction
by: Emine Kacar, et al.
Published: (2019-03-01)

Nitrofurantoin-induced radiation recall dermatitis
by: Ian Garrahy, et al.
Published: (2019-05-01)

Nitrofurantoin and Fosfomycin Susceptibility Among Outpatient Uropathogens in a Tertiary Care Center in Southern Thailand
by: Tharntip Sangsuwan, et al.
Published: (2018-05-01)

EVALUATION OF THE EFFECT OF NITROFURANTOIN ON EXPERIMENTAL CRYPTOSPORIDIUM PARVUM INFECTION IN IMMUNOSUPPRESSED MICE
by: REDA ELBAKARY, et al.
Published: (2025-08-01)

Consider Nitrofurantoin as a Cause of Lung Injury
by: Paulo Almeida, et al.
Published: (2019-10-01)

Combined Effect of Nitrofurantoin and Plant Surfactant on Bacteria Phospholipid Membrane
by: Monika Rojewska, et al.
Published: (2020-05-01)

A rare case of nitrofurantoin‐induced acute lung injury
by: Rehan Karmali, et al.
Published: (2020-10-01)

Nitrofurantoin or Fosfomycin: The better choice for lower urinary tract infection?
by: Sheema Yousuf, et al.
Published: (2025-12-01)

Ultrafast green synthesis of silver nanoparticles as fluorescent nanosensors for determination of isoniazid and nitrofurantoin in biological fluids and pharmaceuticals
by: Galal Magdy, et al.
Published: (2025-05-01)

A pioneering electrochemical sensor for the simultaneous determination of nitrofurantoin and furazolidone residues in food and municipal wastewater samples
by: Wondimeneh Dubale Adane, et al.
Published: (2024-08-01)

In Vitro and In Vivo Trypanocidal Efficacy of Synthesized Nitrofurantoin Analogs
by: Linous Munsimbwe, et al.
Published: (2021-06-01)

Enhanced Drug Dissolution of Nitrofurantoin Using a Solid Dispersion Technique
by: D. S. Bhosale, et al.
Published: (2024-08-01)

Simulating treatment effects for gonorrhoea using a within-host mathematical model
by: Pavithra Jayasundara, et al.
Published: (2026-09-01)

Does Nitrofurantoin Improve the Portfolio of Vets against Resistant Bacteria in Companion Animals?
by: Cristina Vercelli, et al.
Published: (2023-05-01)

Repurposing nitrofurantoin as a stimulant of fibroblast extracellular matrix repair for the treatment of emphysema
by: Mathew N. Leslie, et al.
Published: (2024-09-01)

Fabrication of nitrofurantoin-loaded chitosan-silver nanoparticles for the treatment of urinary tract infections
by: G. N. Ningaraju, et al.
Published: (2026-04-01)

Nitrofurantoin-induced immune-mediated lung and liver disease
by: Milić Rade, et al.
Published: (2012-01-01)

Nitrofurantoin susceptibility profile versus other antibiotics tested in uropathogens- a retrospective study from India
by: Anuja Gupta, et al.
Published: (2024-07-01)

IN-VITRO EFFICACY OF NITROFURANTOIN, CIPROFLOXACIN AND COTRIMOXAZOLE AGAINST VARIOUS URINARY ISOLATES
by: Luqman Satti, et al.
Published: (2015-01-01)

Simultaneous Determination of Nitrofurantoin and Phenazopyridine in Human Urine Samples By HPLC-UV
by: Elsayed Ibrahim, et al.
Published: (2023-01-01)

Recurrent nitrofurantoin-induced giant cell interstitial pneumonia: Case report and literature review
by: Boeun Lee, et al.
Published: (2015-01-01)

Differentiating probable nitrofurantoin-induced drug fever from antipsychotic-induced hyperthermia in a patient receiving clozapine
by: Stephen B. Vickery, PharmD, BCPS, et al.
Published: (2022-06-01)

High-level nitrofurantoin resistance in a clinical isolate of Klebsiella pneumoniae: a comparative genomics and metabolomics analysis
by: Maytham Hussein, et al.
Published: (2024-01-01)

Innovative antimicrobial strategies in endodontics: Comparative evaluation of silver nanoparticles, calcium hydroxide, and nitrofurantoin against Enterococcus faecalis
by: Megha Kaushik, et al.
Published: (2026-04-01)

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin
by: Jitendra Singh, et al.
Published: (2016-01-01)

Analysis of nitrofurantoin sensitivity in multi drug resistant gram negative bacilli causing UTI in a teaching hospital – A cost effective option
by: T Sabarinathan, et al.
Published: (2024-02-01)

Analysis of nitrofurantoin sensitivity in multi drug resistant gram negative bacilli causing UTI in a teaching hospital – A cost effective option
by: T Sabarinathan, et al.
Published: (2024-02-01)

Risks of long-term use of nitrofurantoin for urinary tract prophylaxis in the older patient
by: Lauren L. Rego, et al.
Published: (2016-12-01)

Nitrofurantoin-Induced Pulmonary Toxicity: Mechanisms, Diagnosis, and Management
by: Alan D. Kaye, et al.
Published: (2025-05-01)

Nitrofurantoin-induced splinter hemorrhages: A forgotten culprit
by: Ana Sofia Acosta, MD, et al.
Published: (2024-05-01)

Susceptibility Profile of Nitrofurantoin and Fosfomycin among Carbapenem-resistant Enterobacteriaceae Isolates in UTI from a Tertiary Care Hospital
by: Januki Kalai, et al.
Published: (2023-03-01)

Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in <i>Escherichia coli</i> Isolated in Clinical Urine Samples
by: Antonio Sorlozano-Puerto, et al.
Published: (2020-08-01)